S100A1 and myocardial infarction: The results were more similar to the findings of Fan et al. (2019) in acute myocardial infarction, which indicated that plasma S100A1 levels were significantly higher in the ST-segment elevation myocardial infarction (STEMI) group than in healthy controls.